Tilray Brands (WBO:TLR2) Moat Score: 3/10 (As of Jun. 26, 2026)


WBO:TLR2 Tilray Brands Inc WBO:TLR2
55 GF Score
Price €3.92
GF Value €10.82
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Tilray Brands Moat Score?

Tilray Brands WBO:TLR2 -4.16% 55 Moat Score is 3 as of Jun. 26, 2026. GuruFocus rates WBO:TLR2 with a GF Score™ of 55/100 and a GF Value™ of €10.82 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,033 Drug Manufacturers companies, Tilray Brands ranks better than 86.16% on this metric.

Tilray Brands has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Tilray Brands has No Moat: Tilray operates in a highly competitive cannabis market with low barriers to entry. It lacks significant customer switching costs, strong brand loyalty, or proprietary technology that could provide a durable advantage. While it has some market presence, it does not possess a sustainable market share or significant regulatory barriers.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Tilray Brands might have No Moat - Very weak/transient advantages.

Tilray Brands  (WBO:TLR2) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Tilray Brands Moat Score Related Terms

WBO:TLR2 vs IRWD, BIOA, ESPR: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tilray Brands Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Moat Score distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Moat Score falls into.


WBO:TLR2
55GF Score
Tilray Brands Inc WBO:TLR2
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Tilray Brands (WBO:TLR2) has a Moat Score of 3 as of Jun. 26, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Tilray Brands ranks #143 out of 1033 companies in the Drug Manufacturers industry, placing it in the top 13.8%.
Is Tilray Brands' Moat Score too high?
Tilray Brands' current Moat Score is 3. Based on the distribution chart, Tilray Brands ranks #143 out of 1033 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tilray Brands has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' Moat Score compare to IRWD and BIOA?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #143 out of 1033 companies for Moat Score. This places Tilray Brands in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Tilray Brands's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (WBO:TLR2) is currently considered Possible Value Trap. The stock's GF Value™ is €10.82, compared to a current price of €3.92 — trading 63.8% below its estimated fair value. The current Moat Score is 3. Tilray Brands' overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Tilray Brands (WBO:TLR2), the current Moat Score is 3 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tilray Brands (WBO:TLR2) Overvalued in 2026?

Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued. The current stock price of €3.92 is trading 63.8% below its estimated GF Value™ of €10.82. GuruFocus considers Tilray Brands to be Possible Value Trap.

Key valuation signals for WBO:TLR2:

  • Moat Score: 3
  • GF Value™: €10.82 vs. price of €3.92 (63.8% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the WBO:TLR2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tilray Brands Business Description

Address 265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
55GF Score

Get the complete analysis for WBO:TLR2

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.92
Price
€10.82
GF Value